Devon girl's nightly stomach aches turn out to be rare cancer
Cayla Jones, from Cullompton in Devon, was diagnosed with neuroblastoma last summer and has needed intensive chemotherapy, surgery and radiotherapy to try and tackle it. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2019 Category: Consumer Health News Source Type: news

Four-year-old girl's nightly stomach aches turn out to be rare cancer
Cayla Jones, from Cullompton in Devon, was diagnosed with neuroblastoma last summer and has needed intensive chemotherapy, surgery and radiotherapy to try and tackle it. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2019 Category: Consumer Health News Source Type: news

Donors of Rare Blood Type Sought to Save a Miami Toddler
Zainab Mughal, 2, has cancer. Her treatments depend on frequent blood transfusions, but her blood type is extremely rare. (Source: NYT Health)
Source: NYT Health - January 6, 2019 Category: Consumer Health News Authors: CHRISTINA CARON Tags: Blood Blood Donation Zainab Mughal Indian B antigen Transfusions Neuroblastoma Miami (Fla) Source Type: news

Fourth donor found for two-year-old cancer sufferer with some of 'the rarest blood in the world'
Zainab Mughal's family, who come from Pakistan, have been told she requires transfusions from seven-to-10 donors if she is to have any hope of beating her neuroblastoma. (Source: the Mail online | Health)
Source: the Mail online | Health - January 4, 2019 Category: Consumer Health News Source Type: news

New insights into childhood cancer
(Charit é - Universit ä tsmedizin Berlin) Peripheral nervous system tumors, known as neuroblastoma, are one of the most common types of childhood tumors. As part of an international research endeavor, researchers from Charit é - Universit ä tsmedizin Berlin have studied the genetic factors behind different tumor subtypes and their prognoses. Their findings enable clinicians to predict the precise clinical course of the disease, and to adapt their treatment regimens accordingly. The study has been published in the prestigious journal Science*. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Search for extremely rare blood donor for 2-year-old with cancer
An international search is underway for donors with an extremely rare blood type to help save a 2-year-old Florida girl battling aggressive cancer. Zainab Mughal was diagnosed with neuroblastoma two months ago. She has one of the rarest blood types in the world. Nikki Battiste reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 7, 2018 Category: Consumer Health News Source Type: news

A mechanistic approach to neuroblastoma prognosis and risk
(American Association for the Advancement of Science) A new study reveals key molecular indicators that could help doctors select the best form of treatment for patients with neuroblastoma -- the most common type of cancer in infants. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

A mechanistic classification of clinical phenotypes in neuroblastoma
Neuroblastoma is a pediatric tumor of the sympathetic nervous system. Its clinical course ranges from spontaneous tumor regression to fatal progression. To investigate the molecular features of the divergent tumor subtypes, we performed genome sequencing on 416 pretreatment neuroblastomas and assessed telomere maintenance mechanisms in 208 of these tumors. We found that patients whose tumors lacked telomere maintenance mechanisms had an excellent prognosis, whereas the prognosis of patients whose tumors harbored telomere maintenance mechanisms was substantially worse. Survival rates were lowest for neuroblastoma patients w...
Source: ScienceNOW - December 6, 2018 Category: Science Authors: Ackermann, S., Cartolano, M., Hero, B., Welte, A., Kahlert, Y., Roderwieser, A., Bartenhagen, C., Walter, E., Gecht, J., Kerschke, L., Volland, R., Menon, R., Heuckmann, J. M., Gartlgruber, M., Hartlieb, S., Henrich, K.-O., Okonechnikov, K., Altmü Tags: Medicine, Diseases reports Source Type: news

PHOTOS: How this $1M donation at Levine Children's Hospital aids treatment of rare cancer
Levine Children's Hospital now has a specialized treatment suite for an aggressive form of childhood cancer, thanks to a $1 million donation from the Isabella Santos Foundation. The suite is equipped for MIBG treatment, which uses radiation to target high-risk neuroblastoma, a tumor typically found in the adrenal glands. The suite is divided into a lead-lined room for the child and a separate room for the parents to prevent unneeded radiation exposure. An audio-video syst em allows communication… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 29, 2018 Category: Biotechnology Authors: Caroline Hudson Source Type: news

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways
In this study, we established both phosphoproteomic and gene expression profiles of ALK activity in neuroblastoma cells exposed to first- and third-generation ALK TKIs, to identify the underlying molecular mechanisms and identify relevant biomarkers, signaling networks, and new therapeutic targets. This analysis has unveiled various important leads for novel combinatorial treatment strategies for patients with neuroblastoma and an increased understanding of ALK signaling involved in this disease. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - November 20, 2018 Category: Science Authors: Van den Eynden, J., Umapathy, G., Ashouri, A., Cervantes-Madrid, D., Szydzik, J., Ruuth, K., Koster, J., Larsson, E., Guan, J., Palmer, R. H., Hallberg, B. Tags: STKE Research Resources Source Type: news

Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
Oncogenic anaplastic lymphoma kinase (ALK) is one of the few druggable targets in neuroblastoma, and therapy resistance to ALK-targeting tyrosine kinase inhibitors (TKIs) comprises an inevitable clinical challenge. Therefore, a better understanding of the oncogenic signaling network rewiring driven by ALK is necessary to improve and guide future therapies. Here, we performed quantitative mass spectrometry–based proteomics on neuroblastoma cells treated with one of three clinically relevant ALK TKIs (crizotinib, LDK378, or lorlatinib) or an experimentally used ALK TKI (TAE684) to unravel aberrant ALK signaling pathway...
Source: Signal Transduction Knowledge Environment - November 20, 2018 Category: Science Authors: Emdal, K. B., Pedersen, A.-K., Bekker-Jensen, D. B., Lundby, A., Claeys, S., De Preter, K., Speleman, F., Francavilla, C., Olsen, J. V. Tags: STKE Research Resources Source Type: news

Hope for non-toxic treatment for child cancer
Drug combination promising in treating neuroblastoma Related items fromOnMedica One in 10 children in phase I cancer trials respond to drugs Child cancer drug approved for NHS use Children need access to cancer drug ‘goldmine’ Higher heart risk for survivors of childhood cancer Make greater effort to protect children from methadone (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 16, 2018 Category: UK Health Source Type: news

Clinical trial harnesses power of natural killer cells to treat neuroblastoma
(Solving Kids' Cancer) Researchers use a humanized monoclonal antibody known as hu14.18-IL2, which specifically targets neuroblastoma tumor cells and binds to them. The humanized monoclonal antibody may be more effective at activating the NK cells for killing the cancer cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2018 Category: International Medicine & Public Health Source Type: news

Drug combination makes cancer disappear in mice with neuroblastoma
(ECCO-the European CanCer Organisation) Researchers investigating new treatments for neuroblastoma -- one of the most common childhood cancers -- have found that a combination of two drugs made tumors disappear in mice, making it more effective than any other drugs tested in these animals. The research is presented at the 30th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

A nine-year-old boy who bravely endured years of gruelling treatment is now free of cancer
Henry Hallam, from Plymouth, was diagnosed with neuroblastoma when he was three years old. It affects 100 UK children each year and has one of the lowest survival rates - but he beat it. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2018 Category: Consumer Health News Source Type: news

Translational research on recurrent metastatic neuroblastoma at Children's Hospital Los Angeles
(Children's Hospital Los Angeles) A team of investigators at CHLA designed basic research studies to look at the effects of dinutuximab and activated natural killer cells on recurrent disease and overall survival in neuroblastoma. This research provided proof-of-concept for an upcoming clinical trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2018 Category: Cancer & Oncology Source Type: news

Could Zika Virus Potentially Treat Neuroblastoma?
Researchers report that the same driving force that makes Zika so detrimental to unborn babies gives it promise as a cancer treatment. (Source: CancerNetwork)
Source: CancerNetwork - August 9, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Girl battling a rare cancer for third time meets Little Mix
Rosie Veronica Mitchell,  Port Glasgow, Inverclyde, is battling neuroblastoma - a rare childhood cancer that usually starts in the abdomen. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2018 Category: Consumer Health News Source Type: news

Urgent appeal is underway to send a six-year-old girl abroad for cancer treatment  
Rosie Veronica Mitchell,  Port Glasgow, Inverclyde, is battling neuroblastoma - a rare childhood cancer that usually starts in the abdomen. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2018 Category: Consumer Health News Source Type: news

Solid tumors targeted in new CAR T-Cell immunotherapy trial
(Seattle Children's) Seattle Children's has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system EGFR-expressing solid tumors. In the phase 1 trial, STRIvE-01, cancer-fighting CAR T cells will target the EGFR protein expressed in many childhood sarcoma, kidney and neuroblastoma tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 7, 2018 Category: International Medicine & Public Health Source Type: news

Beat Childhood Cancer Consortium expands into Canada
(Spectrum Health) Helen DeVos Children's Hospital's consortium, known as Beat Childhood Cancer (BCC), announced today that through a partnership with The C17 Council, the organization's first Canadian clinical trial site, Centre Hospitalier Universitaire de Sainte-Justine, Montreal, Quebec, Canada, has been approved to begin recruiting patients for a pivotal clinical trial investigating the potential of a repurposed drug to prevent relapse in patients diagnosed with high-risk neuroblastoma who are currently in remission. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 6, 2018 Category: International Medicine & Public Health Source Type: news

Zika viruses show potential as treatment for high-risk childhood cancer
(Nemours) Zika virus may hold potential as a cancer treatment for neuroblastoma, a rare-but-deadly childhood cancer, according to early findings from basic research published today in PLOS ONE. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 25, 2018 Category: Cancer & Oncology Source Type: news

Cancer drug for children recommended after becoming cost effective for NHS patients
Seriously ill children battling high-risk neuroblastoma, a rare type of cancer that mainly affects children and young people, are to be offered a drug which has potential to extend their lives. (Source: NHS Networks)
Source: NHS Networks - July 12, 2018 Category: UK Health Source Type: news

Child cancer drug approved for NHS use
60% of children with high-risk neuroblastoma can be treated with dinutuximab beta Related items fromOnMedica One in 10 children in phase I cancer trials respond to drugs Children need access to cancer drug ‘goldmine’ NICE rejects adjuvant use of breast cancer drug New breast cancer drug ‘unaffordable’ for NHS Drug could double head and neck cancer survival (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 12, 2018 Category: UK Health Source Type: news

Fluorescent fish genes light path to neuroblastoma
(Rice University) Neurodevelopmental biologist Rosa Uribe, a CPRIT Scholar who was recruited to Rice University in 2017 with a grant from the Cancer Prevention and Research Institute of Texas, has a new tool in the search for the origins of neuroblastoma, the third-most common pediatric cancer in the United States. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 9, 2018 Category: Cancer & Oncology Source Type: news

New model for predicting neuroblastoma outcomes incorporates early developmental signals
(Stowers Institute for Medical Research) Motivated by a desire to better understand the molecular circuitry underlying neuroblastoma and limitations of current methods for predicting disease progression and outcome, researchers from the Kulesa Lab at the Stowers Institute for Medical Research and collaborators at the University of Michigan and Oxford University set out to construct a logic-based model incorporating information about developmental signaling pathways implicated in the disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 6, 2018 Category: Biology Source Type: news

MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine
SAN DIEGO, July 3, 2018 -- (Healthcare Sales & Marketing Network) -- MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical stage oncology drug development company has granted to Y-mAbs Therapeutics, Inc., a privately held clinical stage biopharmac... Biopharmaceuticals, Oncology, Licensing MabVax Therapeutics, Y-mAbs Therapeutics, neuroblastoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2018 Category: Pharmaceuticals Source Type: news

Emerging Role of Immunotherapy for Childhood Cancers Emerging Role of Immunotherapy for Childhood Cancers
Immunotherapeutic strategies are showing promise for pediatric cancers such as leukemia and neuroblastoma. What is the latest research?Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 25, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Novel nuclear medicine approach shows promise for treating wide array of cancerous tumors
(Society of Nuclear Medicine and Molecular Imaging) A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Researchers create novel combination as potential therapy for high-risk neuroblastoma
(Virginia Commonwealth University) Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2018 Category: International Medicine & Public Health Source Type: news

St Louis Cardinals pitcher reveals his one-year-old daughter is battling  cancer
St Louis Cardinals starting pitcher Alex Reyes, 23, revealed publicly for the first time that his one-year-old daughter Aleyka was diagnosed with neuroblastoma when she was just five months old. (Source: the Mail online | Health)
Source: the Mail online | Health - June 13, 2018 Category: Consumer Health News Source Type: news

Childhood Cancer Impacts Mental Health
WEDNESDAY, June 13, 2018 -- Children with neuroblastoma, a pediatric cancer of nerve cells, are vulnerable to mental health and behavioral problems, a new study finds. Neuroblastoma is diagnosed at a median age of 17.3 months. Treatment advances... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 13, 2018 Category: General Medicine Source Type: news

Childhood Neuroblastoma Survivors at Higher Risk for Psych Disorders
(MedPage Today) -- Chronic health conditions predicted impairment (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - June 13, 2018 Category: Psychiatry Source Type: news

Child Neuroblastoma Survivors at Risk for Psych Impairment
MONDAY, June 11, 2018 -- Neuroblastoma survivors are at elevated risk for psychological impairment, according to a study published online June 11 in Cancer. Daniel J. Zheng, M.D., from Yale University in New Haven, Conn., and colleagues evaluated... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 11, 2018 Category: Pharmaceuticals Source Type: news

Children with neuroblastoma have an elevated risk of long-term psychological difficulties
(Wiley) A new study reveals that pediatric neuroblastoma patients are at elevated risk for long-term psychological impairment. In addition, those who experience such impairment as they get older tend to require special education services and to not go on to college. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2018 Category: Cancer & Oncology Source Type: news

Transatlantic clinical trial for neuroblastoma is open in UK -- US and Germany to open soon
This study combines 131-I mIBG with Nivolumab and Dinutuximab beta. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2018 Category: Cancer & Oncology Source Type: news

Decision to not make drug for childhood cancer on NHS 'devastating'
Health watchdog Nice, which advises NHS England, stressed it would like to recommend dinutuximab beta for patients with neuroblastoma – but argued it is too expensive. (Source: the Mail online | Health)
Source: the Mail online | Health - May 4, 2018 Category: Consumer Health News Source Type: news

Decision to not make a drug for childhood cancer on the NHS is 'devastating', say charities
Health watchdog Nice, which advises NHS England, stressed it would like to recommend dinutuximab beta for patients with neuroblastoma – but argued it is too expensive. (Source: the Mail online | Health)
Source: the Mail online | Health - May 4, 2018 Category: Consumer Health News Source Type: news

What Causes Flushing?
Discussion Flushing is usually thought of as a benign condition such as blushing, but can be quite irritating if it is frequent or persistent (i.e. menopausal hot flashes) or even pathologic (i.e. malignancy). “Flushing is a subjective and sensation of warmth that is accompanied by reddening of the skin anywhere on the body but favors the face, neck, and upper torso…. Flushing can be broadly divided into episodic or persistent. Episodic flashing is mediated by the release of endogenous vasoactive mediators or medications, while persistent flushing result in a fixed facial erythema with telangiectasias and cyan...
Source: PediatricEducation.org - April 30, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Removing the enablers: Reducing number of tumor-supporting cells to fight neuroblastoma
(Children's Hospital Los Angeles) Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages -- a type of immune cell -- can negatively affect the response to chemotherapy against neuroblastoma. Their findings suggest that combination therapy might be effective in patients with high-risk disease, even those who have limited anti-tumor T cell responses. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2018 Category: Cancer & Oncology Source Type: news

New biomarkers for neuroblastoma, a type of cancer in children
(University of Gothenburg) Two new biomarkers for a type of cancer in children called neuroblastoma have been identified in a study published in the journal Cancer Cell. The findings are expected to have immediate significance for disease prognosis, and eventually also for treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news

Inspiring battle of siblings both diagnosed with cancer
Two of Emily Neumann's children battled cancer. Her son Rowan, seven, was diagnosed with Leukemia and her daughter Winnie, one, was diagnosed with neuroblastoma. (Source: the Mail online | Health)
Source: the Mail online | Health - March 5, 2018 Category: Consumer Health News Source Type: news

Wakefield woman's two sons are diagnosed with cancer
Keri Redfearn, 32, from Wakefield, thought she was living her worst nightmare when her 10-year-old son Leo was diagnosed with neuroblastoma in October last year. (Source: the Mail online | Health)
Source: the Mail online | Health - February 26, 2018 Category: Consumer Health News Source Type: news

Estrogen causes neuroblastoma cells to mature into neurons
(Karolinska Institutet) The female sex hormone estrogen can perform an important role in neuroblastoma, a form of cancer mainly affecting young children. In laboratory experiments, researchers at Karolinska Institutet in Sweden demonstrate that estrogen treatment and overexpression of the estrogen receptor cause malignant neuroblastoma cells to mature into neuron-like cells. The study, which is published in PNAS, gives hope of new treatment possibilities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2018 Category: Cancer & Oncology Source Type: news

'Hijacker' drives cancer in some patients with high-risk neuroblastoma
(St. Jude Children's Research Hospital) Researchers in Memphis and Boston have collaborated to show c-MYC is an oncogene that drives neuroblastoma in some high-risk patients; the findings help set the stage for much-needed precision medicines (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 22, 2018 Category: Biology Source Type: news

Uncovering molecular targets for childhood cancer therapeutics
(Tokyo Medical and Dental University) Neuroblastoma (NB) is the most common solid tumor found in children and is associated with poor prognosis; however, little is known regarding the molecular targets located in the long arm of chromosome 11 (11q). Tokyo Medical and Dental University (TMDU)-centered researchers revealed the loss or imbalance of genes ATM, MRE11A, H2AFX, and/or CHEK1 in 11q in 20.7% of NBs. Furthermore, they found 83.3% NB-derived cell lines exhibited sensitivity to PARP inhibitors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 28, 2017 Category: Cancer & Oncology Source Type: news

Structural basis of membrane disruption and cellular toxicity by {alpha}-synuclein oligomers
Oligomeric species populated during the aggregation process of α-synuclein have been linked to neuronal impairment in Parkinson’s disease and related neurodegenerative disorders. By using solution and solid-state nuclear magnetic resonance techniques in conjunction with other structural methods, we identified the fundamental characteristics that enable toxic α-synuclein oligomers to perturb biological membranes and disrupt cellular function; these include a highly lipophilic element that promotes strong membrane interactions and a structured region that inserts into lipid bilayers and disrupts their integ...
Source: ScienceNOW - December 14, 2017 Category: Science Authors: Fusco, G., Chen, S. W., Williamson, P. T. F., Cascella, R., Perni, M., Jarvis, J. A., Cecchi, C., Vendruscolo, M., Chiti, F., Cremades, N., Ying, L., Dobson, C. M., De Simone, A. Tags: Biochemistry, Neuroscience reports Source Type: news

MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas
Activation of the RAS-RAF-MEK-ERK signaling pathway is implicated in driving the initiation and progression of multiple cancers. Several inhibitors targeting the RAS-MAPK pathway are clinically approved as single- or polyagent therapies for patients with specific types of cancer. One example is the MEK inhibitor trametinib, which is included as a rational polytherapy strategy for treating EML4-ALK–positive, EGFR-activated, or KRAS-mutant lung cancers and neuroblastomas that also contain activating mutations in the RAS-MAPK pathway. In addition, in neuroblastoma, a heterogeneous disease, relapse cases display an incre...
Source: Signal Transduction Knowledge Environment - November 28, 2017 Category: Science Authors: Umapathy, G., Guan, J., Gustafsson, D. E., Javanmardi, N., Cervantes-Madrid, D., Djos, A., Martinsson, T., Palmer, R. H., Hallberg, B. Tags: STKE Research Articles Source Type: news

Thousands of strangers gave a sick 9-year-old an early Christmas. He died days after celebrating.
Jacob Thompson spent nearly half of his short life battling cancer. The 9-year-old boy, who loved penguins, died Sunday, four years after he was diagnosed with Stage 4 neuroblastoma, a rare cancer that affects mostly young children. As his family had expected, Thompson didn’t live long enough to celebrate Christmas, a holiday he loves. But before his death, […]Related:Risk of stillbirth is double in pregnant women who sleep on their backs, study findsA dying vet needed CPR. Hidden video shows his nurse laughing instead.The truth behind the ‘first marijuana overdose death’ headlines (...
Source: Washington Post: To Your Health - November 21, 2017 Category: Consumer Health News Source Type: news

Boy with cancer dies after wish for early Christmas
Jacob Thompson battled neuroblastoma for four years, and people around the world pitched in to bring him joy in his final days (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 20, 2017 Category: Consumer Health News Source Type: news